{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:26Z","timestamp":1707524546757},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,19]]},"DOI":"10.7759\/cureus.24290","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T18:32:44Z","timestamp":1650393164000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinically Ambiguous Hemorrhagic Cardiac Tamponade Associated with Apixaban"],"prefix":"10.7759","author":[{"given":"Jose S","family":"Aguilar-Gallardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subrat","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arieh","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Singh A, Verma V, Chaudhary R. Direct oral anticoagulants associated hemopericardium. (2021). Accessed. March 1, 2021: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2021\/01\/06\/20\/26\/direct-oral-anticoagulants-associated-hemopericardium."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2019.04.002","article-title":"Hemorrhagic cardiac tamponade associated with apixaban: a case report and systematic review of literature","volume":"20","author":"Asad ZU","year":"2019","unstructured":"Asad ZU, Ijaz SH, Chaudhary AM, Khan SU, Pakala A. Hemorrhagic cardiac tamponade associated with apixaban: a case report and systematic review of literature. Cardiovasc Revasc Med. 2019, 20:15-20. 10.1016\/j.carrev.2019.04.002","journal-title":"Cardiovasc Revasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.16.1810","article-title":"Does this patient with a pericardial effusion have cardiac tamponade?","volume":"297","author":"Roy CL","year":"2007","unstructured":"Roy CL, Minor MA, Brookhart MA, Choudhry NK. Does this patient with a pericardial effusion have cardiac tamponade?. JAMA. 2007, 297:1810-8. 10.1001\/jama.297.16.1810","journal-title":"JAMA"},{"key":"ref4","unstructured":"Apixaban (eliquis) [package insert]. (2012). Accessed. March 4, 2021: https:\/\/www.eliquis.com\/eliquis\/hcp\/efficacy-safety."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"74","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019, 74:104-32. 10.1016\/j.jacc.2019.01.011","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.10.031","article-title":"Usefulness of oximetry paradoxus to diagnose cardiac tamponade","volume":"123","author":"Doukky R","year":"2019","unstructured":"Doukky R, Improvola G, Shih MJ, et al.. Usefulness of oximetry paradoxus to diagnose cardiac tamponade. Am J Cardiol. 2019, 123:498-506. 10.1016\/j.amjcard.2018.10.031","journal-title":"Am J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-017-1477-1","article-title":"Determination of non-vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system","volume":"43","author":"Bliden KP","year":"2017","unstructured":"Bliden KP, Chaudhary R, Mohammed N, et al.. Determination of non-vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system. J Thromb Thrombolysis. 2017, 43:437-45. 10.1007\/s11239-017-1477-1","journal-title":"J Thromb Thrombolysis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50121-3","article-title":"Drug-drug interaction predicting by neural network using integrated similarity","volume":"9","author":"Rohani N","year":"2019","unstructured":"Rohani N, Eslahchi C. Drug-drug interaction predicting by neural network using integrated similarity. Sci Rep. 2019, 9:13645. 10.1038\/s41598-019-50121-3","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25475","article-title":"Reversal of direct oral anticoagulants: guidance from the Anticoagulation Forum","volume":"94","author":"Cuker A","year":"2019","unstructured":"Cuker A, Burnett A, Triller D, et al.. Reversal of direct oral anticoagulants: guidance from the Anticoagulation Forum. Am J Hematol. 2019, 94:697-709. 10.1002\/ajh.25475","journal-title":"Am J Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler Y","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al.. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015, 36:2921-64. 10.1093\/eurheartj\/ehv318","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90540-H","article-title":"Spectrum of hemodynamic changes in cardiac tamponade","volume":"66","author":"Reddy PS","year":"1990","unstructured":"Reddy PS, Curtiss EI, Uretsky BF. Spectrum of hemodynamic changes in cardiac tamponade. Am J Cardiol. 1990, 66:1487-91. 10.1016\/0002-9149(90)90540-H","journal-title":"Am J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92415-clinically-ambiguous-hemorrhagic-cardiac-tamponade-associated-with-apixaban","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:06Z","timestamp":1707507426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92415-clinically-ambiguous-hemorrhagic-cardiac-tamponade-associated-with-apixaban"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.24290","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,19]]}}}